Reading Time: 4 minutes From competitive inhibitors to monoclonal antibodies: what are your options for reversing the direct oral anticoagulants in intracranial hemorrhage?
apixaban
-
-
Reading Time: 2 minutes Can we use a DOAC in a patient with a BMI ≥40 kg/m2 without impacting efficacy or safety?